Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
4(29%)
Results Posted
14%(1 trials)

Phase Distribution

Ph phase_2
1
7%
Ph not_applicable
7
50%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
1(12.5%)
N/ANon-phased studies
7(87.5%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

14

all time

Status Distribution
Active(4)
Completed(7)
Other(3)

Detailed Status

Completed7
Recruiting3
unknown3
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
4
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (12.5%)
N/A7 (87.5%)

Trials by Status

recruiting321%
unknown321%
completed750%
active_not_recruiting17%

Recent Activity

Clinical Trials (14)

Drug Details

Intervention Type
PROCEDURE
Total Trials
14